US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

652.17

-17.0374-2.55%

Number of Gainers:- -

Number of Losers:4

Number of Flat:- -

PE:- -

High:681.04

Open:676.32

Low:640.29

Close:669.21

Volume:28.56M

Turnover:686.21M

Market Cap:20.09B

Float Cap:14.80B

Loading ...

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

Shares of Tempus AI up 8.7% After Deal With Predicta to Expand Access to Genome Test

THOMSON REUTERS

Tempus AI, Predicta Biosciences expand co-branded whole-genome sequencing assay access

Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and Mrd Monitoring

THOMSON REUTERS

Tempus AI Deepens Oncology Role With Automated Updates And AACR 2026 Data

Simply Wall St.

Agilent Technologies (A) Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch

Simply Wall St.

Tempus AI Stock Jumps As Data Presentations Fuel Fresh AI Oncology Buzz

Benzinga_recent_news

Tempus presents real-world study linking KMT2C mutation to platinum therapy survival gain

Reaffirming Buy on CRISPR Therapeutics: Conference Engagement and Gene-Editing Leadership Support Attractive Risk‑Reward

tempus AI Inc Class A call volume above normal and directionally bullish

Tempus AI Initiated at Underperform by Jefferies

Jefferies Initiates Tempus AI at Underperform With $35 Price Target

MT Newswires Live

Tempus AI Inc : TD Cowen Raises to Buy From Hold; Cuts Target Price to $65 From $70

THOMSON REUTERS

Tempus AI upgraded to Buy from Hold at TD Securities

ARK Lightens Stake After Nuclear Stock Hits High

Tempus AI initiated with an Underperform at Jefferies

This Nuclear Stock Had Its Best Day Ever. Cathie Wood's ARK Took the Moment to Sell. -- Barrons.com

BUZZ-U.S. STOCKS ON THE MOVE-Zscaler, Carlyle, Weight Watchers

Tempus AI announce strategic collaboration with Gilead

BUZZ-Tempus AI rises as it expands cancer research partnership with Gilead

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":652.1711,"timestamp":1776369599999,"preClose":669.2085,"halted":0,"volume":28562471,"delay":0,"changeRate":-0.025459,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-17.037415,"latestTime":"04-16 16:00:00 EDT","open":676.3162,"high":681.03937,"low":640.289,"amount":686205904.342131,"amplitude":0.060893,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.017588,"peRate":-12.384835,"turnoverRate":0.04097,"increases":0,"decrements":4,"flats":0,"marketCap":20087868672,"floatMarketCap":14800046464},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":681.03937,"amplitude":0.060893,"preClose":669.2085,"low":640.289,"pbRate":"4.017588","latestPrice":652.1711,"volume":28562471,"delay":0,"open":676.3162,"prevYearClose":658.3995,"prevWeekClose":565.6311,"prevMonthClose":542.5347,"prevQuarterClose":542.5347,"fiveDayClose":568.9471,"twentyDayClose":568.9692,"sixtyDayClose":712.2755,"secType":"PLATE","market":"US","turnoverRate":0.04097,"peRate":-12.384835,"marketCap":20087868672,"floatMarketCap":14800046464,"timestamp":1776369599999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":0,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627306292","title":"Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2627306292","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627306292?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:00","pubTimestamp":1776337200,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., April  16, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to c","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/16/3275169/0/en/Metagenomi-Therapeutics-Inc-Announces-Publication-in-Nature-Structural-Molecular-Biology-Highlighting-Proprietary-Compact-CRISPR-Nuclease-with-Enhanced-Genome-Editing-Efficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRSP","MGX","BK4556","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4588","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627238797","title":"Shares of Tempus AI up 8.7% After Deal With Predicta to Expand Access to Genome Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2627238797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627238797?lang=en_us&edition=fundamental","pubTime":"2026-04-15 22:23","pubTimestamp":1776263002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL4N40Y1DI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU1861559042.SGD","BK4613","TEMT","BK4611","LU1861558580.USD","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627284499","title":"Tempus AI, Predicta Biosciences expand co-branded whole-genome sequencing assay access","url":"https://stock-news.laohu8.com/highlight/detail?id=2627284499","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627284499?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:31","pubTimestamp":1776256277,"startTime":"0","endTime":"0","summary":"Tempus AI entered collaboration with Predicta Biosciences to commercially expand co-branded GenoPredicta whole-genome sequencing assay for hematologic malignancies and measurable residual disease monitoring.Partnership broadens access for Tempus Life Sciences partners to ultrasensitive workflow combining flow cytometry with WGS from peripheral blood or bone marrow.Assay targets sensitivity down to 1 in 1,000,000 cells from as few as 50 tumor cells, supporting diagnosis, risk classification, and treatment-resistance tracking.GenoPredicta has been clinically validated in multiple myeloma and other plasma cell dyscrasias, with other indications offered for research use only.Tempus cited 100% concordance between peripheral blood and bone marrow results, positioning test as alternative to more invasive biopsies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gener","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL2TP8lN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","BK4611","BK4121","LU1861558580.USD","TEM","LU1861559042.SGD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627109284","title":"Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and Mrd Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2627109284","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627109284?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:30","pubTimestamp":1776256201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA3WVCR5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU1861559042.SGD","BK4613","TEMT","LU1861558580.USD","BK4611","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627461407","title":"Tempus AI Deepens Oncology Role With Automated Updates And AACR 2026 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2627461407","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627461407?lang=en_us&edition=fundamental","pubTime":"2026-04-15 16:11","pubTimestamp":1776240669,"startTime":"0","endTime":"0","summary":"Tempus AI (NasdaqGS:TEM) has launched an automated clinical update service tied to its AI-enabled clinician portal for ongoing cancer therapy monitoring.\nThe new service is designed to keep treatment recommendations aligned with current guidelines and emerging options without requiring new patient samples.\nTempus AI reports 31 research abstracts accepted for presentation at AACR 2026, including an oral presentation and a featured session on AI-powered lab technologies.\n\nTempus AI operates at...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-deepens-oncology-role-with-automated-updates-and-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-deepens-oncology-role-with-automated-updates-and-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AIYY","TEMT","BK4588","BK4587","BK4023","BK4551","BK4543","BK4585","BK4611","BK4613","LU1861558580.USD","TEM","VGT","BK4121","BK4528","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627447004","title":"Agilent Technologies (A) Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2627447004","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627447004?lang=en_us&edition=fundamental","pubTime":"2026-04-15 11:07","pubTimestamp":1776222464,"startTime":"0","endTime":"0","summary":"Agilent Technologies (A) is back in focus after two contrasting developments: the Supreme Court left rulings invalidating its CRISPR related patents in place, and the company introduced its new BioTek Cytation 9 cell imaging multimode reader.\nSee our latest analysis for Agilent Technologies.\nAt a share price of $120.39, investors have seen a 7.96% 1 month share price return and a 5.72% 7 day gain. However, the 90 day share price return of 17.50% and year to date share price return of 12.73%...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/154924-main-header/1756254020530","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/154924-main-header/1756254020530"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/agilent-technologies-a-valuation-check-after-crispr-patent-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/agilent-technologies-a-valuation-check-after-crispr-patent-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2041044095.USD","LU1165135440.EUR","LU2413666426.HKD","BK4585","LU2413666699.HKD","LU1861559042.SGD","BK4121","CRSP","LU1861558580.USD","LU2089279066.USD","LU2092937221.SGD","A","IE00BN0W2T93.GBP","BK4611","LU2229751404.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU0347712357.USD","LU1543694498.USD","BK4556","BK4588","BK4567","LU1721428933.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627426171","title":"Tempus AI Stock Jumps As Data Presentations Fuel Fresh AI Oncology Buzz","url":"https://stock-news.laohu8.com/highlight/detail?id=2627426171","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627426171?lang=en_us&edition=fundamental","pubTime":"2026-04-15 02:29","pubTimestamp":1776191340,"startTime":"0","endTime":"0","summary":"Tempus AI gains as AACR 2026 abstracts highlight biomarkers and cancer subtypes, while Jefferies starts coverage with an Underperform rating.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/14/Tempus-Options-Surge.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/14/Tempus-Options-Surge.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/04/51815694/tempus-ai-stock-jumps-data-presentations-fuel-fresh-ai-oncology","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/04/51815694/tempus-ai-stock-jumps-data-presentations-fuel-fresh-ai-oncology","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4585","LU1861558580.USD","LU2125909759.SGD","LU2065171311.SGD","IE00B3S45H60.SGD","LU0950375773.USD","LU2272731600.USD","BK4020","LU2065170008.USD","LU0354030438.USD","TEM","LU2322448791.USD","IE0034235188.USD","LU1861559042.SGD","BK4613","LU1917777945.USD","LU0354030511.USD","LU2065169927.USD","LU1992135472.HKD","LU2272731865.HKD","LU2506951958.HKD","LU1974910355.USD","LU2023250504.SGD","BK4611","LU1992135399.USD","LU2023250843.SGD","LU0823417737.USD","LU2247934214.USD","LU0823417653.USD","TEMT","LU2065171402.SGD","LU2506952097.USD","LU2322448957.HKD","LU1923622291.USD","LU0107464264.USD","LU2473716301.USD","LU2106854487.HKD","IE00B775SV38.USD","LU2272731782.SGD","LU2506952170.USD","LU2506951875.HKD","BK4113","BK4588","LU2125909916.SGD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627344611","title":"Tempus presents real-world study linking KMT2C mutation to platinum therapy survival gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2627344611","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627344611?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:31","pubTimestamp":1776169915,"startTime":"0","endTime":"0","summary":"Tempus disclosed new real-world evidence research that links KMT2C mutations to better outcomes on platinum-based chemotherapy in solid tumors.Findings were already validated in an external cancer dataset, with an oral presentation scheduled for AACR Annual Meeting 2026 on April 20 in San Diego.Colorectal cancer showed strongest signal, positioning KMT2C as potential biomarker to guide chemotherapy selection in GI cancers.Tempus indicated follow-on laboratory work is underway to clarify biological drivers, supporting potential clinical adoption and partner interest in biomarker-led treatment strategies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Busi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL79Nl0T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","TEMT","BK4121","TEM","BK4613","LU1861559042.SGD","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627123448","title":"Reaffirming Buy on CRISPR Therapeutics: Conference Engagement and Gene-Editing Leadership Support Attractive Risk‑Reward","url":"https://stock-news.laohu8.com/highlight/detail?id=2627123448","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627123448?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:16","pubTimestamp":1776165415,"startTime":"0","endTime":"0","summary":"In a report released today, Gil Blum from Needham maintained a Buy rating on Crispr Therapeutics AG, with a price target of $82.00. Gil Blum has gi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/reaffirming-buy-on-crispr-therapeutics-conference-engagement-and-gene-editing-leadership-support-attractive-risk‑reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/reaffirming-buy-on-crispr-therapeutics-conference-engagement-and-gene-editing-leadership-support-attractive-risk‑reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRSP","BK4588","BK4139","BK4556","BK4611","LU1861558580.USD","BK4585","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627463117","title":"tempus AI Inc Class A call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2627463117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627463117?lang=en_us&edition=fundamental","pubTime":"2026-04-14 03:45","pubTimestamp":1776109512,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in tempus AI (TEM) Inc Class A with 14,076 calls trading, 1.3x expected, and implied vol increasing over 1 point to 75...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4587","LU1861558580.USD","BK4613","BK4121","BK4543","TEM","BK4611","TEMT","BK4551","BK4528","BK4585","BK4023","BK4588","LU1861559042.SGD","AIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627558453","title":"Tempus AI Initiated at Underperform by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2627558453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627558453?lang=en_us&edition=fundamental","pubTime":"2026-04-13 20:39","pubTimestamp":1776083940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 13, 2026 08:39 ET (12:39 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","LU1861559042.SGD","LU1861558580.USD","BK4613","TEMT","BK4121","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627437872","title":"Jefferies Initiates Tempus AI at Underperform With $35 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2627437872","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627437872?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:19","pubTimestamp":1776079166,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $72.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861558580.USD","TEM","BK4611","BK7095","LU1861559042.SGD","BK4613","BK4121","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627340284","title":"Tempus AI Inc : TD Cowen Raises to Buy From Hold; Cuts Target Price to $65 From $70","url":"https://stock-news.laohu8.com/highlight/detail?id=2627340284","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627340284?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:54","pubTimestamp":1776077649,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nFWN40W0JS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","BK4613","TEM","TEMT","BK4121","BK4611","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627439226","title":"Tempus AI upgraded to Buy from Hold at TD Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2627439226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627439226?lang=en_us&edition=fundamental","pubTime":"2026-04-13 17:45","pubTimestamp":1776073506,"startTime":"0","endTime":"0","summary":"TD Securities upgraded Tempus AI (TEM) to Buy from Hold with a price target of $65, down from $70. The shares are down over 50% in the last six mon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-upgraded-to-buy-from-hold-at-td-securities-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-upgraded-to-buy-from-hold-at-td-securities-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4551","BK4587","LU1861558580.USD","TEMT","BK4588","AIYY","BK4611","LU1861559042.SGD","BK4528","BK4543","BK4585","AI","TEM","BK4121","BK4566","BK4023","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626614196","title":"ARK Lightens Stake After Nuclear Stock Hits High","url":"https://stock-news.laohu8.com/highlight/detail?id=2626614196","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626614196?lang=en_us&edition=fundamental","pubTime":"2026-04-13 13:28","pubTimestamp":1776058084,"startTime":"0","endTime":"0","summary":"After BWX Technologies had its best day on record, Cathie Wood's ARK Invest shed shares of the nuclear play across two of its flagship funds.The sale included 2,639 shares by the ARK Innovation...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","IE00B19Z4B17.USD","LU1861559042.SGD","BK4187","BWXT","LU0240877869.USD","ARKQ","SG9999014021.USD","BK4591","LU0205194284.USD","BK4556","BK4611","LU0240878834.USD","ARKK","BK4544","SG9999014013.SGD","IE00B66KJ199.SGD","BK4588","BK4567","BK4139","BK4585","SG9999014005.SGD","LU1861558580.USD","LU0205193047.USD","BK4606","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627010440","title":"Tempus AI initiated with an Underperform at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2627010440","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627010440?lang=en_us&edition=fundamental","pubTime":"2026-04-13 07:51","pubTimestamp":1776037900,"startTime":"0","endTime":"0","summary":"Jefferies initiated coverage of Tempus AI (TEM) with an Underperform rating and $35 price target The firm sees “secular tailwinds” in the oncology ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-initiated-with-an-underperform-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-initiated-with-an-underperform-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4587","BK4585","BK4613","LU1861559042.SGD","LU1861558580.USD","TEMT","AIYY","BK4023","BK4528","BK4543","TEM","BK4588","BK4121","BK4611","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626311254","title":"This Nuclear Stock Had Its Best Day Ever. Cathie Wood's ARK Took the Moment to Sell. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2626311254","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626311254?lang=en_us&edition=fundamental","pubTime":"2026-04-11 01:55","pubTimestamp":1775843700,"startTime":"0","endTime":"0","summary":"After BWX Technologies had its best day on record, Cathie Wood's ARK Invest shed shares of the nuclear play across two of its flagship funds.The sale included 2,639 shares by the ARK Innovation exchange-traded fund, which is concentrated in so-called disruptive technology and dominated by names such as Crispr Therapeutics and Advanced Micro Devices. As of Friday, ARK Innovation held 303,133 BWX shares valued at roughly $69.8 million, or 1.17% of the portfolio by weight.The second fund to sell was the ARK Autonomous Technology & Robotics ETF, which shed 839 shares. BWX is the fund's 18th-largest holding by weight, comprising 2.08% of the portfolio. The fund holds 173,687 shares, which were valued at nearly $40 million on Friday.BWX has been a notably strong performer this year, surging 34% against a 0.4% decline for the S&P 500. The stock more than doubled in 2025, driven higher by backlog growth and contract wins with both government and commercial clients. The company counts the Defen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKF","BK4588","ARKW","LU0205193047.USD","SARK","BK4611","LU0205194284.USD","BK4139","LU0240877869.USD","IE00B7SZL793.SGD","BK4187","BK4591","SG9999014013.SGD","IE00B19Z4B17.USD","ARKK","ARKQ","BWXT","ARKG","LU0240878834.USD","LU1861559042.SGD","BK4556","SG9999014021.USD","LU1861558580.USD","BK4606","BK4567","BK4585","IE00B66KJ199.SGD","ARKX","CRSP","BK4544","SG9999014005.SGD","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626136062","title":"BUZZ-U.S. STOCKS ON THE MOVE-Zscaler, Carlyle, Weight Watchers","url":"https://stock-news.laohu8.com/highlight/detail?id=2626136062","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626136062?lang=en_us&edition=fundamental","pubTime":"2026-04-09 23:51","pubTimestamp":1775749867,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Zscaler, Carlyle, Weight WatchersWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL6N40S11Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4149","IE00BWXC8680.SGD","BK4574","LU1823568750.SGD","IE00B19Z9505.USD","TSLI","BK4212","BK4543","ZS","LU2023250504.SGD","LU0323591593.USD","LU2265009873.SGD","LU1084165304.USD","BK4550","LU1989764748.USD","IE00BLSP4239.USD","BK4528","LU2750360641.GBP","IE00BGHQF748.EUR","IE00B894F039.SGD","IE00BMPRXR70.SGD","LU2125910336.SGD","BK4598","LU2298064838.USD","BK4135","WW","LU1366192091.USD","LU1923622614.USD","BK4554","LU2272731865.HKD","LU2357305700.SGD","LU0052756011.USD","LU1804176565.USD","LU0957808578.USD","IE00BBT3K403.USD","IE0034235303.USD","IE00BZ9MQY76.HKD","LU1989772923.USD","LU1992135472.HKD","BK4588","IE00B64PRP62.GBP","LU0056508442.USD","LU0964807845.USD","SG9999015978.USD","BK4520","LU0353189763.USD","LU1169589451.USD","IE00B1XK9C88.USD","LU1429558221.USD","TSLZ","APLX","BLSX","LU1043141123.HKD","TEMT","TSII","LU1267930227.SGD","BK4182","LU2433249047.HKD","LU1861220033.SGD","BK4607","IE00BK4W5L77.USD","LU0689472784.USD","LU2420271590.USD","LU2360106780.USD","LU0198837287.USD","TSLR","LU0786609619.USD","LU2087621335.USD","LU0107464264.USD","BK4585","BK4609","TSLG","LU1691799644.USD","BK4608","BK4503","LU1303367103.USD","LU0320765059.SGD","LU1116320737.USD","LU2290526834.HKD","LU2098885051.SGD","MVLL","BK4612","TSLS","LU1914381329.SGD","TSLP","LU1674673691.USD","LU0345774391.USD","LU0061475181.USD","LU1430594728.SGD","LU0251131958.USD","BK4504","LU2322448791.USD","BK4131","BK4511","LU1066051225.USD","LU1119994496.HKD","BK4548","TSYY","BK4559","LU0719512351.SGD","LU2089985449.USD","LU1153585028.USD","LU1778281490.HKD","APLZ","LU2236285917.USD","TSLQ","LU0444971666.USD","BK4140","LU2458330169.SGD","LU1316542783.SGD","BK4192","LU2458330243.SGD","LU2471134796.USD","SG9999015986.USD","IE00B19Z8W00.USD","TESL","LU0823434740.USD","LU2756315664.SGD","LU2552382215.SGD","LU1803068623.USD","LU0251142724.SGD","LU1923621640.USD","LU2462157665.USD","LU1861559042.SGD","LU1046421795.USD","LU0127658192.USD","LU0158827948.USD","LU0994945656.USD","BK4611","IE00BK4W5M84.HKD","LU1803068979.SGD","LU2403377893.USD","LU0154236417.USD","LU2247934214.USD","LU0426417589.USD","BK4581","LU2244417387.USD","LU0265550946.USD","LU0345770308.USD","BK4169","BK4605","LU1720051017.SGD","LU2213496289.HKD","LU2106854487.HKD","LU0011850046.USD","LU0310800965.SGD","LU0354030511.USD","TLA","LU2271345857.HKD","LU2125909916.SGD","LU2023250843.SGD","CG","BK4097","LU0128525689.USD","LU2322448957.HKD","BK4613","LU1235294995.USD","LU1989772840.SGD","LU1571399168.USD","LU1629891620.HKD","CRWU","LU1066051811.HKD","LU1145028129.USD","LU2750360997.AUD","IE00BSNM7G36.USD","LU1435385759.SGD","LU1988902786.USD","LU0048573561.USD","LU2931357623.SGD","IE00BD6J9T35.USD","BK4023","LU2125909593.SGD","LU0109392836.USD","LU2249611893.SGD","LU0889565833.HKD","BK4532","MRVU","LU2238339852.HKD","LU1267930730.SGD","LU1852331112.SGD","LU1323610961.USD","BK4139","LU2417539215.USD","LU0158827781.USD","BK4116","TSL","LU0426412945.USD","TSLY","BK4560","LU0742534661.SGD","BK4566","LU2125910179.SGD","LU0823411888.USD","LU0348723411.USD","BK4592","LU0820561818.USD","LU0109391861.USD","LU2089283258.USD","CRSH","LU0868494617.USD","LU2272731600.USD","LU2552382058.USD","IE00B19Z9Z06.USD","LU1169590202.USD","LU1923623000.USD","BLSG","LU0345769631.USD","TSDD","BK4121","IE00BMPRXN33.USD","LU2896262040.SGD","LU1839511570.USD","BK4516","IE00B19Z8X17.USD","LU1720051108.HKD","07766","LU2023251221.USD","LU0943347566.SGD","LU0210536198.USD","LU2473716301.USD","SG9999015945.SGD","IE00BJLML261.HKD","LU0354030438.USD","LU2326559502.SGD","BK4112","IE00B3QW5Z07.USD","TSLL","LU1989764664.SGD","LU2237438978.USD","LU2023250330.USD","LU2272731782.SGD","TEST","CWVX","LU1674673428.USD","BK4604","LU0266013472.USD","BK4099","LU0820561909.HKD","LU1974910355.USD","LU0265550359.USD","TSLW","LU0077335932.USD","BK4603","BK4533","NOWL","LU0187121727.USD","CRWG","LU0642271901.SGD","BK4527","LU2471134952.CNY","BK4187","LU0345769128.USD","LU2602419157.SGD","LU2125909247.SGD","LU2543165471.USD","LU1939255532.USD","LU0823434583.USD","LU1861215975.USD","LU0323240290.USD","LU1548497426.USD","LU0672654240.SGD","LU2125909759.SGD","BK4555","LU1121112475.USD","LU1066051498.USD","LU0868494708.USD","LU2381873111.SGD","BK4515","LU0942090050.USD","BK4597","LU1951198990.SGD","IE00B1BXHZ80.USD","BK4141","BK4534","LU0234572021.USD","LU2211817866.USD","BK4167","LU1066053197.SGD","LU2471134523.USD","LU1951200564.SGD","LU2286300806.USD","BK4561","LU0323239441.USD","LU0234570918.USD","LU1232071149.USD","LU0345774631.USD","LU1992135399.USD","LU0316494557.USD","LU1261432733.SGD","LU1642822529.SGD","LU2108987350.USD","LU0708995401.HKD","LU0053666078.USD","LU1585245621.USD","BK4231","LU0444973449.USD","LU1043141396.HKD","LU1721428933.USD","LU2264538146.SGD","LU0081259029.USD","LU0823414478.USD","LU1064131342.USD","TSLT","SG9999015952.SGD","TSLO","IE00B19Z9P08.USD","LU0097036916.USD","SG9999000418.SGD","LU1116320901.HKD","LU0353189680.USD","LU0820562030.AUD","LU0476273544.USD","LU1815336760.USD","BK4080","LU2552382132.HKD","LU2360107168.USD","IE00BN8TJ469.HKD","LU0274383776.USD","LU1551013342.USD","BK4201","LU2089284900.SGD","LU2456880835.USD","LU2756315318.SGD","CORD","LU1983260115.SGD","IE00BLSP4452.SGD","LU2111349929.HKD","LU2250418816.HKD","LU2087625088.SGD","BK4564","LU0082616367.USD","BK4551","LU0390134368.USD","LU1923622291.USD","LU2063271972.USD","LU0466842654.USD","BK4213","BK4198","LU1917777945.USD","LU1551013425.SGD","LU2028103732.USD","LU2471134879.HKD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626133542","title":"Tempus AI announce strategic collaboration with Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2626133542","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626133542?lang=en_us&edition=fundamental","pubTime":"2026-04-09 22:18","pubTimestamp":1775744333,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an expanded, multi-year collaboration with Gilead Sciences (GILD) aimed at building and advancing Gilead’s oncology pipel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announce-strategic-collaboration-with-gilead-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announce-strategic-collaboration-with-gilead-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEM","LU1066051498.USD","LU1066053197.SGD","BK4566","AIYY","SG9999015952.SGD","IE00BKVL7J92.USD","LU1585245621.USD","BK4585","LU1037948897.HKD","LU1057294990.SGD","IE00B19Z3581.USD","BK4587","LU0823416689.USD","LU0234570918.USD","LU1037948541.HKD","BK4528","BK4611","LU0882574055.USD","BK4578","LU0965508806.USD","TEMT","LU0965509010.AUD","LU0109394709.USD","LU2089984988.USD","SG9999015986.USD","BK4543","SG9999015945.SGD","LU1934455863.HKD","SG9999015978.USD","BK4613","LU0122379950.USD","LU0058720904.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1674673428.USD","LU1778281490.HKD","LU0965509283.SGD","LU1839511570.USD","IE00BZ1G4Q59.USD","GILD","LU1934455194.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","IE00B3T34201.USD","LU1571399168.USD","LU1861559042.SGD","LU1934455277.USD","LU2112291526.USD","BK4023","LU0114720955.EUR","LU0320765992.SGD","LU0861579265.USD","LU1023059063.AUD","LU2087621335.USD","LU2324357040.USD","IE00B19Z3B42.SGD","BK4121","BK4139","IE0002270589.USD","BK4551","LU1674673691.USD","LU2468319806.SGD","BK4550","BK4583","LU0889565916.HKD","LU0965509101.SGD","LU1061106388.HKD","BK4568","BK4588","LU1861558580.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626182743","title":"BUZZ-Tempus AI rises as it expands cancer research partnership with Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2626182743","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626182743?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:49","pubTimestamp":1775738983,"startTime":"0","endTime":"0","summary":"BUZZ-Tempus AI rises as it expands cancer research partnership with Gilead** Shares of healthcare AI firm Tempus AI TEM.O rise 1.5% to $47.99 premarket** Co says it has expanded its multi-year partnership with Gilead GILD.O to support cancer drug research** Collaboration gives Gilead wider access to Tempus’ real-world patient data and AI tools, which analyze medical records from cancer patients - TEM** Gilead will use the platform to design clinical trials, choose drug targets and study treatment outcomes, co says** Says partnership aims to speed up development of cancer medicines by combining Tempus’ data insights with Gilead’s drugmaking expertise** Gilead has previously utilized TEM's data for its oncology research, including trial design, health outcomes analysis and clinical evidence** As of last close, stock down ~20% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL4N40S11A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4588","BK4532","SG9999015952.SGD","BK4613","GILD","IE00B7SZLL34.SGD","LU1430594728.SGD","BK4583","LU0109394709.USD","LU0114720955.EUR","LU0234570918.USD","LU1037948897.HKD","LU1023059063.AUD","IE00B19Z3B42.SGD","BK4611","LU0823416689.USD","LU1037948541.HKD","BK4139","BK4121","LU1066053197.SGD","IE00B3T34201.USD","LU0320765992.SGD","LU1839511570.USD","LU1934455194.USD","LU1674673428.USD","LU1934455863.HKD","LU2112291526.USD","LU2468319806.SGD","LU1778281490.HKD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0058720904.USD","IE0002270589.USD","BK4566","LU2089984988.USD","TEMT","LU1934455277.USD","LU0889565916.HKD","LU0965508806.USD","BK4550","TEM","LU0965509101.SGD","LU1585245621.USD","LU1066051498.USD","LU1674673691.USD","BK4568","LU1061106388.HKD","SG9999015978.USD","LU1861559042.SGD","LU0882574055.USD","LU1861558580.USD","LU2087621335.USD","BK4585","LU0289739699.SGD","SG9999015986.USD","LU0965509010.AUD","BK4578","LU0965509283.SGD","LU1571399168.USD","IE00BSNM7G36.USD","LU0861579265.USD","LU0122379950.USD","SG9999015945.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}]}}